Press Releases

Leukocare and Malvern collaborate on stabilization and formulation development of COVID-19 vaccines

Leukocare appoints Professor Ulrike Protzer as member to the Scientific Advisory Board

Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area

Leukocare announces formation of Scientific Advisory Board

Europas Hotspot der Corona- Bekämpfung

ReiThera, LEUKOCARE and Univercells announce pan-European consortium for the fast-track development of a single-dose adenovirus-based COVID-19 vaccine

Coronavirus (COVID-19) statement LEUKOCARE has implemented and executes a Business Continuity Plan (BCP) - We remain fully operational for our clients

LEUKOCARE to publish new data on stable liquid viral vector formulations

LEUKOCARE´s 7th Scientific Formulation Symposium

LEUKOCARE to participate at several European Conferences